Reproductive and Mental Health in Aplastic Anemia
Part of Blood & lymphatic clinical trials.
This study looks at how aplastic anemia affects reproductive and mental health in adults. By understanding these connections, doctors can provide better support for your overall well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with aplastic anemia (a condition where your bone marrow doesn't make enough blood cells).
- You are between 18 and 40 years old.
- You are willing and able to follow the study rules and sign a consent form.
- You do not have inherited bone marrow failure, other blood diseases, or a history of mental illness or reproductive system cancer.
- You are not pregnant, breastfeeding, or receiving chemotherapy that caused your bone marrow failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether N-acetylcysteine (NAC), a common supplement, can help your bone marrow recover faster after a stem cell transplant for severe aplastic anemia. If you qualify, you'll receive NAC alongside your standard transplant care.
This study tests an experimental cell therapy called CK0801 for people with aplastic anemia who still need blood transfusions despite prior treatment. The goal is to see if it can help your bone marrow recover and reduce transfusion needs.
This study is testing whether a stem cell transplant (from a matched relative, unrelated donor, or half-matched donor) can help adults aged 40–60 with severe aplastic anemia that didn't get better or came back after standard treatments.
This trial tests adding romiplostim to standard care for severe aplastic anemia (a condition where the bone marrow doesn't make enough blood cells) in patients aged 2 to 21. It aims to see if this combination improves blood cell counts in those newly diagnosed or whose disease has come back or not responded to prior treatment.
This trial tests a new type of transplant using donated cord blood for adults with aplastic anemia that has not improved with standard treatments. It aims to see if the transplant is safe and effective.
This study tests if the drug rituximab can help people with severe aplastic anemia whose bodies have stopped responding to platelet transfusions. It aims to see if rituximab can improve the body's ability to accept platelets again.
Hear when a new Aplastic Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.